New work from Fred Hutch Cancer Center virologists shows that gene drive, which pushes a trait through a population, occurs ...

CAIA is supported by more than $40 million in funding and the best and latest AI technology and expertise from AWS, Deloitte, Microsoft, NVIDIA and Slalom to launch the coordination and computation ...

Fred Hutch researchers explain in the journal Nature Microbiology why some HIV-1 variants are more transmissible than others, ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Dr. Michael Emerman studies how our cells interact with HIV and related retroviruses. Over millennia, our cells and the cells of other primates that are susceptible to retrovirus infection have ...

Dr. Keith Jerome is a renowned virologist whose research focuses on viruses such as herpes simplex, HIV and hepatitis B that persist in their hosts. He studies the ways in which these viruses evade ...

The Atlas of Inspiring Hispanic/Latinx Scientists is a grassroots effort developed to showcase the expertise, talents, and diversity of Hispanic and Latinx scientific faculty. Featured scientists were ...

Fred Hutch Cancer Center is expanding its research footprint in South Lake Union with three buildings on Eastlake Avenue East that will add more than 300,000 square feet devoted to labs and flexible ...

Dr. Andrew Cowan is a hematologist-oncologist who specializes in treating patients with multiple myeloma and other blood disorders. He leads clinical trials of new treatments for these diseases, ...

Fred Hutch’s collaborative culture allows our researchers to generate discoveries as quickly as possible and translate them into new treatments, diagnostic tools and preventive strategies. Our ...

SEATTLE – September 27, 2024 – Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in ...